The Jess and Mildred Fisher Center For Hereditary Cancer and Clinical Genomics Research

As of March 2015, we are pleased to announce our Center’s new name.  The Fisher Center’s expanded title beyond familial cancer research reflects our commitment to leveraging advancements in genomic medicine to improve the medical and quality of life outcomes   of women and men with or at increased risk for cancer.   

Since its establishment in 2006, the Fisher Center has gained local and national recognition for cutting-edge research and expertise in the field of cancer genetic counseling and testing. As the Fisher Center has matured, the field of cancer genomics has grown to encompass the study of thousands of genes and how they interact with the environment to cause disease.  These advances have led to personalized treatments based not only on an individual’s hereditary cancer risks, but also on his or her tumor genomic profile (which assesses non-hereditary mutations).

Fisher Center members are actively engaged in research and education in hereditary cancer and clinical cancer genomics.  To reflect our expanded scope, we broadened the Center’s name to encompass these new initiatives and our comprehensive work.    We look forward to working together with our community of colleagues, research participants, and students to fulfill the mission and vision of the Fisher Center for Hereditary Cancer and Clinical Genomics.  

Clinical Genetic Counseling and Testing

If you have a personal or family history of cancer and would like more information about genetic counseling and testing, please call (202) 444-2223.

For Women and Men Who Have Tested Positive for a BRCA1 or BRCA2 Mutation

To see our Spring 2014 newsletter designed just for you, click here.  

PROMPT:  Prospective Registry of MultiPlex Testing

This national and international online research registry is for patients and families who:

  • Have had multiplex genetic testing -- a newer form of testing that looks for mutations in several genes all at once
  • Have a harmful genetic change or uncertain variant which may be linked to an increased risk of cancer

The Fisher Center directors and genetic counselors are actively involved in PROMPT, which is supported by Memorial Sloan Kettering Cancer Center, the Mayo Clinic Cancer Center, the Dana Farber Cancer Institute, and the Abramson Cancer Center at the University of Pennsylvania.

For more information, please visit

Contact Information for the Fisher Center

3300 Whitehaven Street, NW
Suite 4100
Washington, DC 20007-2401
Fax: (202) 687-8444
E-mail us here.